| Financial Year |
March 31 2023 |
| Monetary Funds |
5,546,047,467.53 |
| Held-for-trading Financial Assets |
100,031,703.60 |
| Notes Receivable |
-- |
| Accounts Receivable |
41,870,754.27 |
| Advances to Suppliers |
5,130,924.79 |
| Other Receivables |
42,519,589.19 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
29,734,404.78 |
| Inventories |
5,403.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
494,560,637.49 |
| Other Current Assets |
262,034,836.59 |
| Total Current Assets |
6,492,201,316.46 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
3,267,066,917.66 |
| Long-term Equity Investment |
3,796,524,931.03 |
| Investment Properties |
-- |
| Fixed Assetes |
1,176,324,646.79 |
| Under-construction Projects |
57,907,023.25 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
8,882,929,192.29 |
| R&D expenses |
-- |
| Goodwill |
2,725,259.09 |
| Long-Term Deferred and Prepaid Expenses |
26,144,230.48 |
| Deferred Income Tax Assets |
32,842,102.38 |
| Other Non-Current Assets |
2,614,698,423.45 |
| Sub-Total of Non-Current Assets |
20,129,637,093.93 |
| Total Assets |
26,621,838,410.39 |
| Short-Term Loans |
3,301,431,237.12 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,073,648,309.13 |
| Accounts Received In Advance |
662,210.09 |
| Employee Compensation Payable |
46,154,954.47 |
| Taxes Payable |
70,150,863.28 |
| Interest Payable |
-- |
| Dividend Payable |
6,493,257.60 |
| Other payables |
162,744,582.79 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
616,256,497.12 |
| Other Current Liabilities |
25,972.96 |
| Sub-Total of Current Liabilities |
5,271,074,626.96 |
| Long-term Loans |
6,226,520,275.66 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
52,658,547.87 |
| Other Non-Current Liabilities |
25,774,834.94 |
| Sub-Total of Non-Current Liabilities |
6,488,056,774.11 |
| Total Liabilities |
11,759,131,401.07 |
| Paid-In Capital(Or Share Stock) |
1,039,516,992.00 |
| Capital Surplus |
1,138,201,472.60 |
| Surplus Reserve |
1,160,546,972.77 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
5,867,260,148.36 |
| Minority Stockholder's Interest |
4,057,433,004.19 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
10,805,274,005.13 |
| Owner's Equity（Stockholder's Equity） |
14,862,707,009.32 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
26,621,838,410.39 |
